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The C terminus of transcription factor NusA from Escherichia coli
comprises two repeat units, which bind during antitermination to
protein N from phage . To delineate the structural basis of the
NusA–N interaction, we attempted to crystallize the NusA C-
terminal repeats in complex with a N peptide (residues 34–47).
The two NusA domains became proteolytically separated during
crystallization, and crystals contained two copies of the first repeat
unit in contact with a single N fragment. The NusA modules
employ identical regions to contact the peptide but approach the
ligand from opposite sides. In contrast to the -helical conforma-
tion of the N N terminus in complex with boxB RNA, residues
34–40 of N remain extended upon interaction with NusA. Muta-
tional analyses indicated that only one of the observed NusA–N
interaction modes is biologically significant, supporting an
equimolar ratio of NusA and N in antitermination complexes.
Solution studies indicated that additional interactions are fostered
by the second NusA repeat unit, consistent with known compen-
satory mutations in NusA and N. Contrary to the RNA polymerase
 subunit, N binding does not stimulate RNA interaction of NusA.
The results demonstrate that N serves as a scaffold to closely
oppose NusA and the mRNA in antitermination complexes.
Phage  regulates transcriptional termination events to switchbetween its life cycles (1, 2). Early gene expression is
regulated by a 107-residue unstructured phage-encoded
polypeptide, N, which recognizes a signal sequence, boxB, in the
untranslated region of the mRNA and thus initiates the buildup
of a multifactor ribonucleoprotein complex on the surface of the
RNA polymerase (RNAP). This protein–RNA assembly bestows
on RNAP the capability to read through -dependent and
intrinsic termination sites. Apart from N and the consecutive
boxA and boxB mRNA sequences (the nut site), the host-derived
N-utilization substances (NusA, B, E, and G) are components of
the antitermination complex.
The N-dependent antitermination complex is characterized
by a multitude of mutual interactions between its protein and
RNA components (3, 4). Within this network, different regions
of N interact with boxB RNA (N residues 1–22), NusA (N
residues 34–47), and RNAP (N residues 73–107) (5, 6). The
interaction of a N fragment with boxB RNA is accompanied by
the local folding of the peptide into a kinked -helix (7–9). The
atomic structures of other regions of N in complex with their
binding partners are presently unknown.
Apart from participating in the N-dependent antitermination
process, NusA is a general modifier of RNAP during the
elongation phase of transcription. Bacterial NusA harbors an
N-terminal domain (NTD) that constitutes a major interaction
site with RNAP (10). Furthermore, it features in tandem one S1
and two K-homology (KH) RNA binding domains. NusA pro-
teins from Escherichia coli and other -proteobacteria carry an
additional C-terminal extension, which is made up of a dually
repeated acidic domain of70 residues (10, 11). These modules
are referred to as acidic repeats (AR) 1 and 2. Although isolated
E. coli NusA does not bind well to nut site RNA (3, 12), the factor
is known to contact the nascent transcript in transcription
complexes (13, 14). Recently, it was shown that the NusA
C-terminal extension hinders RNA interaction in isolation but is
sequestered in transcription complexes by the C-terminal do-
main (CTD) of RNAP subunit  (-CTD) (10, 12, 15). N binds
to the same region of NusA as -CTD, but it has not been
ascertained whether this interaction enhances NusA–RNA bind-
ing as well. In any case, the C-terminal NusA repeats constitute
a versatile protein–protein interaction region because they can
form a complex with the -CTD, N, and, presumably, the
remainder of NusA during inhibition of RNA binding. Whether
the interaction sites for these ligands on AR1–AR2 are the same
or different is not known.
We have attempted to crystallize the dual AR of E. coli NusA
in complex with the cognate region of N. The two NusA
domains became proteolytically separated during crystallization,
and the structure revealed two binding modes of AR1 to N.
Mutation analyses suggested that only one AR1–N contact is
physiologically relevant and that an additional N interaction
site exists on AR2. Our studies suggest that N serves as a
scaffold that brings NusA into proximity of the mRNA nut site.
Materials and Methods
Cloning, Overexpression, and Purification of NusA Constructs. Clon-
ing of the E. coli nusa gene and gene fragments was performed
by using standard molecular biological techniques. The NusA
proteins were overexpressed in E. coli M15 and purified by
various column chromatographic steps. Details of these and the
following protocols are given in Supporting Materials and Meth-
ods, which is published as supporting information on the PNAS
web site.
Crystallographic Procedures. A mixture of NusA AR1–AR2 and
N(34–47) crystallized under ammonium sulfate conditions in
space group P43212. Crystals were derivatized with potassium
bis(cyano)aurate, and anomalous diffraction data were collected
at beamline BW6 of the Deutsches Elektronen Synchrotron
(Table 2, which is published as supporting information on the
PNAS web site). Indexing, integration, and reduction of the
diffraction data were carried out with DENZO/SCALEPACK (16).
Heavy atom sites were determined with SHELXD (17). Pro-
grams from the Collaborative Computational Project Number 4
(CCP4) suite (18) were used for phase calculations (MLPHARE)
and density modification (DM). ARP/WARP (19) was used to
generate a first atomic model, which was manually modified with
Abbreviations: AR, acidic repeat; CTD, C-terminal domain; -CTD, CTD of RNAP subunit ;
ITC, isothermal titration calorimetry; KH, K-homology; NTD, N-terminal domain; RNAP,
RNA polymerase.
Data deposition: The structure coordinates have been deposited in the Protein Data Bank,
www.pdb.org (PDB ID code 1U9L).
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MAIN (www-bmb.ijs.sidocindex.html) and refined by standard
procedures. The structure coordinates have been deposited in
the Protein Data Bank (PDB ID code 1U9L).
Mass Spectrometric Analyses. Mass spectra were recorded with a
matrix-assisted laser desorption ionizationtime-of-f light mass
spectrometer (Bruker Daltronic, Bremen, Germany) with
-cyano-cinnamic acid as the matrix. The spectra were recorded
in reflection mode (fingerprinting) or linear mode (full-length
sample) with external spectral calibration (20).
Molecular Modeling Studies. Protein sequences were aligned by
using BLAST (21), and homology modeling was performed by
using the HOMOLOGY package of INSIGHT II (Accelrys, San
Diego) with AR1 residues 353–419 as the template. Relaxation
of all protein atoms except atoms of the secondary structure
elements was allowed during minimization. Energy minimiza-
tion was performed by using the DISCOVER module of INSIGHT
II for 9,990 cycles, employing a steepest-descent gradient until
the average derivative fell 0.01 kcalmol per Å.
Isothermal Titration Calorimetry (ITC). ITC measurements were
carried out at 20°C by using an MCS-ITC Instrument (Microcal
Software, Northampton, MA) to obtain enthalpy and heat
capacity changes (22). The data were analyzed with ORIGIN
(Version 5.0, Microcal). For interpretation of the data, exact
protein and peptide concentrations were determined by UV
spectroscopy and quantitative amino acid analyses, respectively.
CD Measurements. CD spectra for NusA AR1–AR2 were re-
corded with a J-715 spectropolarimeter (Jasco, Tokyo) and the
protein at a concentration of 0.2 mgml in 50 mM TrisHCl (pH
7.0)150 mM NaCl2 mM DTT. The spectra were interpreted as
a mixture of helical, sheet, and random-coil structure. For
interpretation of the spectra, the exact protein concentration was
determined by UV spectroscopy.
Results and Discussion
Crystal Contents and Quality of the Structure. For crystallization, we
mixed a C-terminal NusA fragment, residues A350–A495, which
covered the entire dual AR region (AR1–AR2), with a synthetic
peptide spanning residues 34–47 of N. Crystals were obtained
only after prolonged incubation times. Their structure could be
solved by a two-wavelength multiple anomalous diffraction
strategy, using a gold derivative (Table 2). The experimental
electron-density map could be interpreted in terms of two copies
of AR1 (AR1A and AR1B) in complex with a single N fragment
(Fig. 1 A and B). The AR2 domain was not seen in the structure.
Refinement converged at an RRfree factor of 21.5%24.0% for
all data up to a 1.9-Å resolution, maintaining the model in
Fig. 1. Structure of the (NusA AR1)2–N complex. (A) Ribbon plot of the (NusA AR1)2–N complex (blue, AR1A; cyan, AR1B). The N(34–40) peptide (red sticks)
is sandwiched between the two AR1 1–2 loops. N and C termini are labeled. Structure figures were prepared with PYMOL (www.pymol.org). (B) Portion of the
final 2Fo Fc electron-density map, which covers residues 34–40 of the N peptide, contoured at the 1 level. (C Left) Electrostatic surface potentials calculated
separately for the binding partners in the physiological complex. Red, negative potential; blue, positive potential. A charge complementarity at the peptide
interface can be clearly discerned. (C Right) Surface representation of the N(34–40) peptide with NusA AR1B displayed as a gray ribbon (prepared with
SWISSPDBVIEWER, http:us.expasy.orgspdbvmainpage.html). (D) Sequence alignment of AR1 and AR2. Numbering above and below the alignment corresponds
to AR1 and AR2, respectively. The background of identical residues is red, and the background of conserved amino acids is yellow. Secondary structure elements
as found for AR1 are indicated. Blue arrows indicate residues of AR1 (D364–D366), which align in a -like arrangement with I37–S39 of the peptide. Prepared
with ALSCRIPT (36).








excellent stereochemistry (Table 2). The mean residual coordi-
nate error estimated from Cruickshank’s diffraction data preci-
sion indicator amounted to 0.17 Å.
Extensively washed crystals and mother liquor were analyzed
by MS (data not shown). Three major peaks were seen for the
crystalline sample, which corresponded to the entire synthetic
N peptide (residues N34–R47) and to regions A350–Q421 and
A350–S424 of NusA AR1. In drops that had not yet developed
crystals or in mother liquor surrounding the crystals, a NusA
fragment corresponding to residues A418–A495, matching the
region of AR2, was seen in addition. All NusA-derived peaks
were verified by peptide mass fingerprinting. Therefore, the N
peptide survived the crystallization period intact so that part of
the peptide (residues N41–R47) must be disordered in the
crystals. In contrast, the link between the two NusA domains was
proteolytically severed, and only AR1 crystallized in complex
with the N fragment, whereas AR2 remained in the superna-
tant fraction. Because their connection can be cleaved, the two
C-terminal NusA domains probably are linked by a flexible
element.
Structure of the NusA Acidic C-Terminal Repeats. Although the
crystal structure of the NTD and the S1KH region of NusA has
been determined (23), no experimental structure is available so
far for the C-terminal repeats. The two crystallographically
independent AR1 molecules of the current structure display an
almost identical, all-helical fold (rms deviation of 0.64 Å for all
common C atoms). Five -helices (1–5) are arranged as two
perpendicularly packed helix–hairpin–helix motifs (Fig. 1 A).
The axes of the helices within the two pairs, 1–2 and 4–5,
are almost parallel, different from the approximately perpen-
dicular arrangement of helices in helix–turn–helix motifs (24).
Helix 3 serves as a connector (Fig. 1 A). Duplication of a
helix–hairpin–helix motif to a (helix–hairpin–helix)2 domain is
also known from other proteins (24). The structure of AR1 is
consistent with previous motif predictions (12) and recent NMR
assignments for the NusA C-terminal extension (25).
Structural similarity searches (26, 27) assigned AR1 to the
sterile  motif fold, an important protein–protein interaction
module found in diverse protein families (28). In addition,
various nucleic acid-binding proteins were identified that carry
closely related motifs to NusA AR1. In these latter proteins, the
helix–hairpin–helix portions are known or expected to interact
with nucleic acids. The hairpin loops of these proteins, which are
contacting the nucleic acids, are rich in positively charged
residues and usually contain a consensus GhG (h, hydrophobic
amino acid) fingerprint (24, 29). In contrast, the surface of AR1
is decisively negatively charged (Fig. 1C). Therefore, it is unlikely
that AR1 constitutes a nucleic acid-binding module besides its
known function as a protein-binding domain (see also below).
Based on the crystal structure of AR1, we have devised a 3D
homology model of AR2. Consistent with the high sequence
similarity (Fig. 1D), the AR2 model closely resembled the AR1
fold with an rms deviation of 1.33 Å between all common C
atoms. It maintained a proper hydrophobic core during energy
minimization and displayed conserved residues at similar posi-
tions to AR1. The surface electrostatic features of the AR2
model matched those of AR1. The secondary structure content
determined from a CD spectrum of the AR1–AR2 repeat
(47.1% helix) closely corresponded to the helical content pre-
dicted from the crystal structure of AR1 and the model of AR2
(51% helix; data not shown). Therefore, AR2 presumably har-
bors a very similar fold to AR1.
Structure of the (NusA AR1)2–N Peptide Complex. In an asymmetric
unit of the present crystal structure, the 1–2 loops of the two
AR1 domains run alongside each other in opposite directions.
The N peptide is sandwiched between these loops (Fig. 1 A).
Peptide residues I37–S39 build up a short parallel -like ar-
rangement with residues D364–D366 of one AR1 domain and
engage in a short antiparallel -like association with the same
residues of the other AR1 molecule (Fig. 1 A). Thus, the same
regions of the two NusA fragments are engaged in the contacts
to the peptide, but these interactions aim at opposite surfaces of
N. Upon complex formation, 700 Å2 of combined surface
area are covered by the AR1A–N contact, whereas850 Å2 are
buried in the AR1B–N complex.
The peptide is seen in an extended conformation and thus
exposes a large number of chemical functionalities to the envi-
ronment, explaining how a rather short stretch of N suffices to
build up a specific complex with NusA AR1. This conformation
is quite different from that of the first 22 residues of N in
complex with a boxB RNA hairpin. Although protein N is
unfolded in isolation, its N-terminal region assumes an -helical
structure upon interaction with boxB RNA (9). Van Gilst, von
Hippel, and coworkers (8) have shown that NusA interacts with
an unfolded region of N and that the conformation of this
region is independent of boxB RNA binding, consistent with the
present findings.
The present structure indicates that AR1 comprises a major
N binding site of NusA, in agreement with other biochemical
studies. Mah et al. (10) demonstrated that a NusA fragment
containing AR1 is necessary for binding to N, whereas the
C-terminal 80 amino acids, encompassing AR2, are dispensable.
However, it could not be excluded that AR2 does engage in
additional contacts to N that were not reflected in the assays.
To test whether the observed AR1–N(34–40) interaction is
stable in solution, we conducted electrophoretic gel-mobility
shift assays. A peptide corresponding to N (residues 1–40)
efficiently bound to synthetic boxB RNA (Fig. 4, which is
published as supporting information on the PNAS web site).
NusA AR1–AR2 alone did not interact with the RNA, even at
very high concentrations, consistent with the acidic nature of the
protein (see above and Fig. 4). However, NusA AR1–AR2 was
Table 1. Interactions of NusA AR1–AR2 with N peptides
N peptide Sequence Kd, M Ha, calmol Sa, calmol per K Stoichiometry
N(34–47) NRPILSLNRKPKSR 3.55  0.11 9,452  24.01 27.77 0.965  0.003
N(31–43) KPVNRPILSLNRK 9.65  0.23 13,350  50.92 22.58 1.263  0.003
N34A KPVARPILSLNRK 13.48  0.23 12,700  53.09 21.21 0.862  0.002
R35A KPVNAPILSLNRK Below DL Below DL Below DL Below DL
P36A KPVNRAILSLNRK 12.86  0.24 15,340  56.77 29.96 1.087  0.003
I37A KPVNRPALSLNRK Below DL Below DL Below DL Below DL
L38A KPVNRPIASLNRK Below DL Below DL Below DL Below DL
S39A KPVNRPILALNRK 41.24  0.46 10,650  41.32 16.25 1.229  0.003
L40A KPVNRPILSANRK Below DL Below DL Below DL Below DL
Below DL, below detection limit; A, mutated residue.
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capable of supershifting the N(1–40)–boxB complex (Fig. 4).
These results indicate that region 41–47 of N is dispensable for
rudimentary binding to NusA AR1–AR2.
N Peptides Interact Exclusively and Stoichiometrically with AR1–AR2
of NusA. Quantitative Western blot analysis of antitermination
complexes has suggested that two NusA molecules may be in
contact with N during antitermination (30). These results could
explain the binding of two AR1 modules to a single N peptide
seen in the present crystal structure. Alternatively, only one of
the observed AR1–N interaction modes may be physiologically
relevant. To distinguish between these possibilities, we studied
the interactions between various NusA and N constructs in
solution by ITC. The amount of heat released after injections of
peptides into solutions of NusA was used to derive the dissoci-
ation constants, enthalpies and entropies of the interactions, and
stoichiometries between the binding partners (Table 1 and
Fig. 2).
For these binding studies, we chose a fragment of N spanning
residues K31–K43. It expands the region that is in contact with
AR1 in the crystal structure by three residues on either side to
reduce end effects. First, we verified in solution that the N
peptides interacted within the C-terminal region of NusA. The
binding affinity of N(31–43) to the NusA AR1–AR2 region (Kd
 9.6 M) was comparable to its affinity for full-length NusA
(Kd  7.9 M). In contrast, a NusA fragment covering only the
NTD and the S1KH region, but lacking AR1–AR2, completely
lost its ability to bind the N peptide (data not shown). There-
fore, the AR1–AR2 region is exclusively responsible for the
binding of N.
Because full-length NusA binds the peptide equally well or
slightly better than AR1–AR2, the N binding site on the
C-terminal repeats must be directly accessible in the framework
of the full-length NusA protein. ITC results reveal that the
enthalpic contribution to peptide binding is less favorable for
full-length NusA than for the AR1–AR2 fragment (8,544
calmol vs. 13,350 calmol, respectively), but the difference is
made up by a more favorable entropic term (5.8 calmol per
K vs. 22.58 calmol per K, respectively). Thus, in full-length
NusA, the AR1–AR2 module may be fixed by intramolecular
contacts so that a loss in entropy upon interaction with the
peptide is reduced as compared with free AR1–AR2. These
results support the notion that the AR1–AR2 region interacts
with the remainder of NusA, as suggested for the autoinhibition
of RNA binding (12).
Approximately equimolar interaction stoichiometries were
observed for various N peptides and NusA constructs (Table 1
and Fig. 2), indicating that in solution one NusA monomer binds
one peptide substrate. This finding contradicts the idea that the
present crystal structure reflects an in vivo situation, in which
two NusA molecules bind by means of AR1 to the same region
of N. The NusAN binding stoichiometry in antitermination
complexes is an unresolved issue. In agreement with our results,
other studies have shown that NusA binds N in a 1:1 complex
in vitro (3, 5, 31). Furthermore, NusA binds stoichiometrically to
RNAP in the absence of N both in vitro (32, 33) and in vivo (30).
Therefore, the 2:1:1 interaction of NusANRNAP may result
from the purification of the complexes under low salt (30).
Identification of the Biologically Relevant Complex by Alanine Scan-
ning. In the next series of experiments, mutated N(31–43)
peptides were tested for binding to NusA AR1–AR2 (Table 1
and Fig. 2). Significantly, N residues, which upon mutation to
alanine displayed reduced affinity, were found to preferentially
or exclusively engage with domain AR1B of the crystal structure
(cyan in Fig. 1 A).
In detail, N34 is not in direct contact with either of the AR1
modules (Fig. 3), and, consequently, binding of N34A is similar
to that of the wild-type peptide (Table 1). The R35 side chain,
alternatively, is poking deeply into a crevice of AR1B. It forms
a salt bridge to O2 of D364B (superscripts identify the AR1
molecule) and hydrogen bonds to the carbonyl oxygen of R409B
(Fig. 3). In addition, a water molecule mediates an interaction to
the carbonyl atom of Y362B. A second water molecule connects
N	2 and the carboxyl function of E408B. The intimate contacts
Fig. 2. Probing of the NusA–N interactions by ITC. (A) Reaction of NusA
AR1–AR2 with N(31–43). (B) Reaction of NusA AR1–AR2 with N(34–47). The
negative peaks indicate an exothermic reaction. The area under each peak
represents the heat released after an injection of the peptide into the solution
of NusA. (Lower) Binding isotherms obtained by plotting peak areas against
the molar ratio of N peptide to NusA. The lines represent the best-fit curves
obtained from least-squares regression analyses assuming a one-site binding
model.








to AR1B are responsible for the complete loss of binding upon
deletion of the R35 side chain (Table 1). Mutation of the peptide
residue P36 to alanine shows only a marginal reduction in
binding affinity (Table 1). P36 stacks on the aromatic ring of
F369 from AR1A (Fig. 3). If this interaction were important, a
more severe loss of affinity would have been expected, discred-
iting the significance of the N–AR1A interaction. A proline at
position 36 may be preferred slightly over other residues because
of a more favorable entropy of interaction, as supported by the
data (Table 1). I37 engages in very similar hydrophobic contracts
to both AR1 molecules, so the loss of affinity of the I37A mutant
cannot discriminate the relevant interaction. Replacement of
L38 with an alanine results in complete loss of binding to NusA
AR1–AR2 (Table 1). One side of residue L38 favorably interacts
with I365 and F369 of AR1B (Fig. 3). At the same time, L38
points to the same side of the peptide as its P36 and L40 side
chains. It thus seems to stabilize the extended peptide confor-
mation through hydrophobic interactions with the latter two
residues. S39 displays only a single specific contact, a hydrogen
bond to D366 O1 of AR1B (Fig. 3). The dissociation constant
of the S39A mutant is 4-fold higher than that of the wild-type
peptide (Table 1), again identifying AR1B as the relevant
interaction partner. The side chain of L40 exclusively interacts
with AR1B. It is in hydrophobic contact with L398B and V372B
and stacks on the aromatic ring of F369B (Fig. 3). A smaller
residue would not be able to fill this hydrophobic pocket. In
agreement, the corresponding L40A mutant has lost its affinity
for NusA AR1–AR2 entirely (Table 1).
Taken together, the AR1B–N complex of the current crystal
structure constitutes a specific and biologically important inter-
action, because four of the seven peptide residues tested are
absolutely required for NusA binding (Table 1). This finding is
consistent with the larger surface area buried by the AR1B–N
complex (see above). Furthermore, the electrostatic surface
potentials of AR1B and the peptide are compatible with an
intimate interaction (Fig. 1C). In particular, the electropositive
patch around R35 of the peptide fits nicely into an electroneg-
ative pocket of AR1B. Single-residue mutations in the peptides,
which completely abolished binding, support the biological
relevance of the observed interactions despite the rather high
dissociation constants. The NusA–N contacts occur within the
framework of a large number of protein–protein and protein–
RNA interactions (3, 4), and the antitermination complexes are
assembled on the surface of RNAP. Therefore, an enhancement
of the individual binary interactions can be expected because of
networking, proximity, and local concentration effects in vivo.
Furthermore, additional NusA–N interactions may lead to an
enhanced affinity in vivo (see below).
AR2 Contributes to N Binding. Full-length N binds to full-length
NusA with a Kd of 70 nM (5), demonstrating contacts beyond
those characterized herein. N(34–47), which was used for
crystallization, corresponds to a mapped NusA binding site on
N (6). The seven amino acids, 41–47, which are contained in the
present crystals (see above) but do not engage in contacts to
AR1, may harbor an additional binding site for AR2. We tested
the affinity of N(34–47) toward AR1–AR2 by ITC. Indeed, the
dissociation constant of N(34–47) was 3-fold lower than that of
N(31–43) (3.5 M vs. 9.6 M) (Table 1 and Fig. 2). A
concomitant and independent binding of the two halves of
N(34–47) to AR1 and AR2, respectively, would explain that
loss of one of the two ARs in NusA has only a minor effect on
N binding (10). In support of this notion, the homology model
of AR2 maintains an electronegative surface similar to that of
AR1 and can be seen easily to engage in a complex with the
positively charged region 41–47 of N. In addition, the sequence
of N(34–40) (NRPILSL) resembles that of N(41–47) (NRK-
PKSR), suggesting that residues 41–47 of N may bind in a
similarly extended conformation to AR2 as seen in the AR1–
N(34–40) complex.
Previous results have indicated that the entire NusA interac-
tion region of N is contained in residues 34–107 (5, 6) and that
residues 241–495 of NusA hold its entire N interaction region
(10). Our results demonstrate that region 34–47 of N and
full-length NusA interact with a Kd of 3.5 M. Therefore,
additional interactions that confer the 70 nM dissociation con-
stant must encompass NusA 241–495 and N 47–107. The pun
mutations of N, which restore N function in a nusA1 mutant
background (34), map within and adjacent to the suspected
AR2-interaction region of N (35) (K45R, punA134; S50R,
Fig. 3. Stereoview detailing the AR1–N(34–40) interaction. The backbone ribbons of the AR1A and AR1B molecules are in blue and cyan, respectively. Residues
interacting specifically with the peptide are shown as sticks and are color-coded by atom type (gray, carbon; red, oxygen; blue, nitrogen). The N peptide is drawn
as a stick figure (pink, carbon). Three water molecules, which are mediating interactions, are shown as green spheres. Hydrogen bonds or salt bridges discussed
in the text are indicated as dashed lines.
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punA150; and I55M, punA165). NusA1 is a point mutation in the
core of the NusA S1 domain and may lead to a reduction in RNA
affinity (23). Assuming that tight NusA–N binding is the result
of an interaction between AR1 and N(34–40) (this crystal
structure) of a similar AR2–N(41–47) interaction and of
additional, uncharacterized interactions between N(48–55) and
AR2 yields a simple interpretation of the genetic data: The pun
mutations could compensate for weakened S1 domain–RNA
interactions in NusA1 with increased AR2–N(pun) binding
affinity.
N Binding to NusA Does Not Enhance Its RNA Affinity. Full-length
NusA is capable of efficient RNA binding only in the presence
of -CTD of RNAP, whereas NusA lacking the last 80 amino
acids (i.e., AR2) can bind RNA without the intervention of the
RNAP  subunit (12). Thus, AR2 in the full-length protein in
some fashion occludes the RNA binding domains, e.g., by
directly folding back onto the S1KH region. The activation of
RNA binding may occur by alternative interaction of AR2 with
-CTD. The present studies infer that AR2, in addition, interacts
with N. The dual role of AR2 as a main interaction site for the
-CTD and a binding site for N could be the main switch
through which NusA is either directed to stimulate pausing and
termination (-CTD) or antitermination (N). We therefore
tested whether N binding also stimulates NusA–RNA interac-
tion similarly to the -CTD (12) through gel-mobility shift
experiments, using radiolabeled nut site RNA, full-length E. coli
NusA, and various N peptides. We restricted the N peptides
to all or part of the NusA binding region because the strong boxB
RNA affinity of the N-terminal part of N (Fig. 4) would mask
any RNA binding by NusA. Contrary to the findings with
-CTD, none of the N peptides tested stimulated nut site RNA
binding by NusA (Fig. 4). Similar results were obtained with
boxA RNA or boxB RNA oligomers instead of the entire nut site
(data not shown). Complementary evidence comes from the
work of others, in which the interaction of NusA and N was
found to be independent of RNA binding (5, 31). These results
demonstrate that the interactions of N or -CTD with AR2
have different physiological consequences, possibly because the
two proteins interact with different surfaces of AR2. The
aforementioned observation that full-length NusA binds equally
well or better than the AR1–AR2 fragment to N is consistent
with this notion. N can interact with the AR1–AR2 region
without liberating AR2 from its interaction with the S1KH
portion; in contrast, -CTD may target the surface of AR2,
which is used to block RNA binding pockets on NusA.
The NusA binding site on N (residues 34–47) directly
neighbors the N interaction site for boxB RNA (residues 1–22).
Although residues 34–47 alone do not stimulate RNA binding by
NusA, it is likely that the close apposition of the nut site and
NusA through the N scaffold will facilitate NusA–mRNA
interactions.
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